申请人:The Board of Regents of the University of Texas System
公开号:US20150157633A1
公开(公告)日:2015-06-11
The present invention generally relates to protein signalling. In particular, compounds that inhibit the Wnt protein signalling pathway are disclosed. Such compounds may be used in the treatment of Wnt protein signalling-related diseases and conditions such as cancer, degenerative diseases, type II diabetes and osteopetrosis.
[EN] WNT PROTEIN SIGNALLING INHIBITORS<br/>[FR] INHIBITEURS DE LA SIGNALISATION PAR LA PROTÉINE WNT
申请人:UNIV TEXAS
公开号:WO2013169631A2
公开(公告)日:2013-11-14
The present invention generally relates to protein signalling. In particular, compounds that inhibit the Wnt protein signalling pathway are disclosed. Such compounds may be used in the treatment of Wnt protein signalling-related diseases and conditions such as cancer, degenerative diseases, type II diabetes and osteopetrosis.
Saksena, R. K.; Yasmeen, Rana, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1987, vol. 26, p. 290 - 293